| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 750335 | (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.0171439890681608 | 0.13661497 |
| NSC 750421 | Null | 0.0171439890681608 | -0.24608987 |
| NSC 750743 | (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.0171439890681608 | -0.19522051 |
| NSC 752461 | Null | 0.0171439890681608 | -0.21810174 |
| NSC 754109 | ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate | 0.0171439890681608 | 0.028076992 |
| NSC 756134 | GSK1023156A | 0.0171439890681608 | -0.16790958 |
| NSC 12198 | Dromostanolone Propionate | 0.0181211508101519 | -0.18555214 |
| NSC 125347 | Null | 0.0181211508101519 | -0.1872439 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0181211508101519 | -0.28373015 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0181211508101519 | -0.36911745 |